[go: up one dir, main page]

FI902350A0 - Fibronektin bindande protein samt dess framstaellning. - Google Patents

Fibronektin bindande protein samt dess framstaellning.

Info

Publication number
FI902350A0
FI902350A0 FI902350A FI902350A FI902350A0 FI 902350 A0 FI902350 A0 FI 902350A0 FI 902350 A FI902350 A FI 902350A FI 902350 A FI902350 A FI 902350A FI 902350 A0 FI902350 A0 FI 902350A0
Authority
FI
Finland
Prior art keywords
protein
bindande
fibronektin
dess framstaellning
samt
Prior art date
Application number
FI902350A
Other languages
English (en)
Other versions
FI102768B1 (fi
FI102768B (fi
Inventor
Magnus Hoeoek
Klas Joensson
Kjell Martin Lindberg
Lars Christer Signaes
Original Assignee
Alfa Laval Agri Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri Int filed Critical Alfa Laval Agri Int
Publication of FI902350A0 publication Critical patent/FI902350A0/fi
Application granted granted Critical
Publication of FI102768B1 publication Critical patent/FI102768B1/fi
Publication of FI102768B publication Critical patent/FI102768B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546Integrin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI902350A 1989-05-11 1990-05-10 Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin v almistamiseksi FI102768B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8901687A SE8901687D0 (sv) 1989-05-11 1989-05-11 Fibronectin binding protein as well as its preparation
SE8901687 1989-05-11

Publications (3)

Publication Number Publication Date
FI902350A0 true FI902350A0 (fi) 1990-05-10
FI102768B1 FI102768B1 (fi) 1999-02-15
FI102768B FI102768B (fi) 1999-02-15

Family

ID=20375920

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902350A FI102768B (fi) 1989-05-11 1990-05-10 Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin v almistamiseksi

Country Status (15)

Country Link
US (3) US5175096A (fi)
EP (1) EP0397633B1 (fi)
JP (1) JP3077993B2 (fi)
AT (1) ATE125867T1 (fi)
AU (1) AU630950B2 (fi)
CA (1) CA2016521C (fi)
DE (1) DE69021263T2 (fi)
DK (1) DK0397633T3 (fi)
ES (1) ES2077666T3 (fi)
FI (1) FI102768B (fi)
GR (1) GR3017946T3 (fi)
IE (1) IE72968B1 (fi)
NO (1) NO300069B1 (fi)
NZ (1) NZ233614A (fi)
SE (1) SE8901687D0 (fi)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5851794A (en) * 1990-10-22 1998-12-22 Alfa Laval Ab Collagen binding protein as well as its preparation
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
DE69434437T2 (de) * 1993-02-05 2006-04-06 Smithkline Beecham P.L.C., Brentford Fibronektinbindungsprotein, monoklonaler antikoerper und ihre verwendung zur verhuetung der adhäsion von bakterien
US5492819A (en) * 1993-09-23 1996-02-20 Genencor International, Inc. Recovery of insoluble biosynthetic products
US6033907A (en) * 1995-09-29 2000-03-07 Indiana University Foundation Enhanced virus-mediated DNA transfer
US7083979B1 (en) * 1994-03-25 2006-08-01 Indiana University Foundation Methods for enhanced retroviral-mediated gene transfer
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6040137A (en) * 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
US20040247611A1 (en) * 1994-05-23 2004-12-09 Montana State University Identification of pathogen-ligand interactions
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
CN1326999C (zh) * 1995-09-29 2007-07-18 印地安纳大学研究及科技有限公司 使用含有病毒和细胞结合区域的分子增强病毒介导的dna转移的方法
GB9521146D0 (en) * 1995-10-16 1995-12-20 Smithkline Beecham Plc Novel compounds
WO1997014801A1 (en) * 1995-10-16 1997-04-24 Smithkline Beecham Plc Novel cell surface protein compounds
US6013482A (en) * 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
US5858709A (en) * 1996-10-15 1999-01-12 Smithkline Beecham P.L.C. Fibronectin binding protein B compounds
US6274376B1 (en) * 1996-02-20 2001-08-14 Smithkline Beecham Corporation ClpL
US6348584B1 (en) * 1996-10-17 2002-02-19 John Edward Hodgson Fibronectin binding protein compounds
JP5124062B2 (ja) * 1997-01-21 2013-01-23 ザ・テキサス・エイ・アンド・エム・ユニバーシテイ・システム フィブロネクチン結合タンパク質組成物および使用法
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6270992B1 (en) * 1997-07-29 2001-08-07 Smithkline Beecham Corporation Histidine kinase of Staphylococcus aureus
GB9720633D0 (en) * 1997-09-29 1997-11-26 Univ Bristol BHV-2 vector
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU2002309650A1 (en) * 2001-05-08 2002-11-18 The Texas A And M University System Highly conserved proteins from gram-positive bacteria
US6835378B2 (en) 2001-05-11 2004-12-28 The Texas A&M University System University Method and compositions for inhibiting thrombin-induced coagulation
WO2002102829A2 (en) 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
US7115264B2 (en) * 2001-11-05 2006-10-03 Inhibitex Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
KR20050099536A (ko) 2003-02-06 2005-10-13 트리펩 아베 글리코실화된 특이성 교환체
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
CN1787839B (zh) * 2003-03-07 2011-09-28 惠氏控股公司 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) * 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
PT2298347E (pt) 2003-05-06 2016-01-29 Biogen Hemophilia Inc Proteínas quiméricas de fator de coagulação para o tratamento de um disturbio hemostático
EP2301957A3 (en) 2004-05-21 2011-05-18 Wyeth LLC Altered fibronectin-binding protein of staphylococcus aureus
NZ553775A (en) 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition for use in vaccination against staphylococcei
EA020459B1 (ru) 2006-03-30 2014-11-28 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
AU2008292897B2 (en) * 2007-08-31 2015-01-22 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US8758765B2 (en) * 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
CN102333540B (zh) 2008-10-06 2015-04-22 芝加哥大学 与细菌eap、emp和/或adsa蛋白相关的组合物和方法
KR20170102039A (ko) 2009-04-03 2017-09-06 유니버시티 오브 시카고 단백질 A(SpA) 변이체와 관련된 조성물 및 방법
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US9364516B2 (en) 2010-02-03 2016-06-14 University Of Rochester Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
CA2803298C (en) 2010-07-02 2020-07-14 The University Of Chicago Compositions and methods related to protein a (spa) variants
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CN103906535B (zh) 2011-08-15 2017-07-14 芝加哥大学 与葡萄球菌蛋白a的抗体相关的组合物和方法
ES2806945T3 (es) 2012-04-26 2021-02-19 Univ Chicago Antígenos de coagulasa estafilocócica y métodos para su uso
CN104703622B (zh) 2012-04-26 2017-05-24 芝加哥大学 与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
TWI745671B (zh) 2013-03-15 2021-11-11 美商百歐維拉提夫治療公司 因子ix多肽調配物
CN105384800B (zh) * 2015-12-07 2019-01-25 黑龙江八一农垦大学 金黄色葡萄球菌taf融合蛋白制备方法及其应用
EP3257862A1 (en) * 2016-06-16 2017-12-20 ETH Zürich Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy
IL291821A (en) 2019-10-02 2022-06-01 Janssen Vaccines & Prevention Bv Staphylococcus peptides and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917818A (en) * 1970-01-14 1975-11-04 Agricura Labor Ltd Treatment of mastitis in cows, the product for this treatment and to the production of said product
DE2644622C3 (de) * 1976-10-02 1979-11-29 Behringwerke Ag, 3550 Marburg Extraktion von Mikroorganismen und diese enthaltende diagnostische Mittel
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
SE446688C (sv) * 1982-09-14 1989-10-16 Magnus Hoeoek Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE454403B (sv) * 1984-05-30 1988-05-02 Alfa Laval Agri Int Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
US5320951A (en) * 1987-06-01 1994-06-14 Hoeoek Magnus Fibronectin binding protein as well as its preparation
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
US5571514A (en) * 1987-06-01 1996-11-05 Alfa Laval Ab Fibronectin binding protein as well as its preparation
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
SE9002617D0 (sv) * 1990-08-10 1990-08-10 Alfa Laval Agri Int A fibronectin binding peptide

Also Published As

Publication number Publication date
NO902082L (no) 1990-11-12
FI102768B1 (fi) 1999-02-15
EP0397633A2 (en) 1990-11-14
US5175096A (en) 1992-12-29
NO300069B1 (no) 1997-04-01
ES2077666T3 (es) 1995-12-01
JP3077993B2 (ja) 2000-08-21
US5840846A (en) 1998-11-24
FI102768B (fi) 1999-02-15
DE69021263T2 (de) 1996-01-04
AU5481890A (en) 1990-11-15
DK0397633T3 (da) 1996-01-02
CA2016521C (en) 2002-02-05
CA2016521A1 (en) 1990-11-11
AU630950B2 (en) 1992-11-12
EP0397633A3 (en) 1991-07-31
NO902082D0 (no) 1990-05-10
DE69021263D1 (de) 1995-09-07
US5652217A (en) 1997-07-29
ATE125867T1 (de) 1995-08-15
NZ233614A (en) 1991-12-23
EP0397633B1 (en) 1995-08-02
IE72968B1 (en) 1997-05-07
JPH03272687A (ja) 1991-12-04
SE8901687D0 (sv) 1989-05-11
GR3017946T3 (en) 1996-02-29
IE901696L (en) 1990-11-11

Similar Documents

Publication Publication Date Title
FI902350A0 (fi) Fibronektin bindande protein samt dess framstaellning.
SE8702272L (sv) Fibronektinbindande protein samt dess framstaellning
ATE361362T1 (de) Gene von moraxella, die für transferrin- rezeptoren kodieren.
DE68929430D1 (de) Fibronektin bindendes Protein
FI922865A (fi) Kollagen-bindande protein samt dess framstaellning.
DE68918519D1 (de) DNA, welche für ein antikoagulierendes Polypeptid kodiert.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ALFA-LAVAL AGRI INTERNATIONAL AKTIEBOLAG